Royalty Pharma Plc Asset Resilience Ratio

Latest as of March 2026: 0.11%

Royalty Pharma Plc asset resilience ratio. Royalty Pharma Plc (RPRX) has an Asset Resilience Ratio of 0.11% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Royalty Pharma Plc to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$21.90 Million

Cash + Short-term Investments

Total Assets

$19.82 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Royalty Pharma Plc (2000–2025)

Asset resilience ratio of Royalty Pharma Plc from 2000 to 2025. This chart shows how Royalty Pharma Plc's Asset Resilience Ratio has changed over time. Read total liabilities of Royalty Pharma Plc for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Royalty Pharma Plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see RPRX current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$21.90 Million	0.11%
Total Liquid Assets	$21.90 Million	0.11%

Asset Resilience Insights

Limited Liquidity: Royalty Pharma Plc maintains only 0.11% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Royalty Pharma Plc Industry Peers by Asset Resilience Ratio

Compare Royalty Pharma Plc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai Medicilon Inc SHG:688202	Biotechnology	6.69%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.76%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%

Royalty Pharma Plc Asset Resilience Ratio by Year (2000–2025)

Royalty Pharma Plc asset resilience ratio by year from 2000 to 2025. The table below shows the annual Asset Resilience Ratio data for Royalty Pharma Plc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.10%	$18.80 Million	$19.62 Billion	-4.52pp
2024-12-31	4.62%	$841.97 Million	$18.22 Billion	+0.00pp
2023-12-31	4.62%	$756.74 Million	$16.38 Billion	+0.35pp
2022-12-31	4.26%	$717.04 Million	$16.81 Billion	-2.94pp
2021-12-31	7.21%	$1.26 Billion	$17.52 Billion	+2.55pp
2020-12-31	4.66%	$983.00 Million	$21.10 Billion	+0.27pp
2019-12-31	4.39%	$547.01 Million	$12.45 Billion	+0.33pp
2018-12-31	4.06%	$461.82 Million	$11.37 Billion	-83.35pp
2007-12-31	87.41%	$24.12 Million	$27.60 Million	+16.06pp
2006-12-31	71.35%	$5.60 Million	$7.85 Million	-11.60pp
2005-12-31	82.95%	$14.67 Million	$17.68 Million	+10.29pp
2004-12-31	72.66%	$4.80 Million	$6.61 Million	+64.34pp
2003-12-31	8.32%	$2.00 Million	$24.03 Million	-51.80pp
2002-12-31	60.12%	$16.45 Million	$27.37 Million	-17.18pp
2001-12-31	77.30%	$28.54 Million	$36.91 Million	+16.82pp
2000-12-31	60.48%	$24.42 Million	$40.37 Million	--

pp = percentage points

About Royalty Pharma Plc

NASDAQ:RPRX USA Biotechnology

Market Cap

$29.78 Billion

Market Cap Rank

#898 Global

#396 in USA

Share Price

$67.18

Change (1 day)

+1.90%

52-Week Range

$37.31 - $67.18

All Time High

$67.18